C Sanyika1, P Corr, D Royston, D F Blyth. 1. Department of Radiology, University of Natal, Faculty of Medicine, Private Bag 7, Congella 4013, Kwazulu Natal, South Africa.
Abstract
PURPOSE: To identify the role of pulmonary angiography in the diagnosis and treatment of severe hemoptysis due to cavitary pulmonary tuberculosis. METHODS: Selective pulmonary angiography was performed on eight patients with severe hemoptysis uncontrolled by previous bronchial and systemic arterial embolization. RESULTS: Three (38%) patients had Rasmussen aneurysms, which were successfully embolized with steel coils. Five patients demonstrated pulmonary arterial hypoperfusion in the diseased lung. CONCLUSIONS: We recommend pulmonary angiography in cavitary tuberculous patients with severe hemoptysis who do not respond to systemic arterial embolization. Rasmussen aneurysms are effectively treated by steel coil occlusion.
PURPOSE: To identify the role of pulmonary angiography in the diagnosis and treatment of severe hemoptysis due to cavitary pulmonary tuberculosis. METHODS: Selective pulmonary angiography was performed on eight patients with severe hemoptysis uncontrolled by previous bronchial and systemic arterial embolization. RESULTS: Three (38%) patients had Rasmussen aneurysms, which were successfully embolized with steel coils. Five patients demonstrated pulmonary arterial hypoperfusion in the diseased lung. CONCLUSIONS: We recommend pulmonary angiography in cavitary tuberculouspatients with severe hemoptysis who do not respond to systemic arterial embolization. Rasmussen aneurysms are effectively treated by steel coil occlusion.
Authors: Fernando Ferreira Gazzoni; Luiz Carlos Severo; Edson Marchiori; Marcos Duarte Guimarães; Tiago Severo Garcia; Klaus L Irion; José Jesus Camargo; José Carlos Felicetti; Flavio de Mattos Oliveira; Bruno Hochhegger Journal: Lung Date: 2014-03-11 Impact factor: 2.584
Authors: Clément Picard; Antoine Parrot; Véronique Boussaud; Armelle Lavolé; Faycal Saidi; Charles Mayaud; Marie France Carette Journal: Intensive Care Med Date: 2003-09-13 Impact factor: 17.440